This profile was last updated on //
Is this you? Claim your profile.
IMS Health Incorporated
83 Wooster Heights Road
IMS Health Incorporated (IMS) is a provider of market intelligence to the pharmaceutical and healthcare industries. It offers products and services, including product and portfolio management capabilities; commercial effectiveness innovations; managed car
Find other employees at this company (9,098)
(164 Total References)
As health systems around the world ...
As health systems around the world grapple with macroeconomic pressures and the demand for expanded access and improved outcomes, different countries have adopted their own approaches to making reimbursement decisions about specific drugs, especially cancer treatments, says Murray Aitken, executive director, IMS Institute for Healthcare Informatics.
IMS Health Senior Vice President and Executive Director, IMS Institute for Healthcare Informatics
Portfolio Management 2008
Murray Aitken, Senior Vice President, Healthcare Insight, IMS Health Inc.
Speaker:Murray Aitken, ...
Speaker:Murray Aitken, Executive Director, IMS Institute for Healthcare Informatics
Topic: "Ten Harbingers of Disruptive Change"
Murray Aitken is the Executive Director of the IMS Institute for Healthcare Informatics.
Established in 2011, the Institute provides policy setters and decision makers in the global health sector with objective, transformational insights into healthcare dynamics derived from granular analysis of information.
Mr. Aitken previously served in other roles at IMS Health since 2001.
Mr. Aitken was previously a partner at McKinsey & Company where he was based in the New Jersey, Seoul, and Los Angeles offices.
He received an M.B.A. degree with distinction from Harvard University, and holds a Master of Commerce degree from the University of Auckland in New Zealand.
DANBURY, CT, December 18, 2014 - ...
DANBURY, CT, December 18, 2014 - New approaches for determining how much drugs should cost, and for setting the price for innovative treatments, were highlighted in a keynote presentation by Murray Aitken, IMS Health senior vice president and executive director of the IMS Institute for Healthcare Informatics, at the Forbes Healthcare Summit held earlier this month in New York City.
In his remarks, Aitken focused on three ways that big data can drive a more constructive understanding of the role and value of medicines in total patient treatment, costs and outcomes:
, "At a time of heightened interest in the cost of innovative medicine treatments, the application of big data provides us with an opportunity to rethink conventional approaches to pricing.